Sensyne appoints banks to consider potential MBO

Clinical AI company Sensyne Health has begun a formal sale process after founder and CEO Lord Paul Drayson put forward proposals for a management buyout. Drayson, the London-listed company’s largest shareholder, hopes to get backing from third-party investors for the MBO. The Sensyne Board has appointed JP Morgan Cazenove and Peel Hunt to consider the…